Breast Cancer Highlights From ASCO 2026: ADCs, Biomarkers, and Earlier Treatment Strategies Take Center Stage
Amol Akhade: What The Devil Wears Prada 2 Taught Me About Oncology?
Alexandre Chan: Real-World Safety of Antibody–Drug Conjugates
Khizra Ahmad: Covering ASCO26 from Front-Row Seat as OncoDaily Ambassador
IMMUNIB Study Uptades: Nivolumab Plus Lenvatinib in Unresectable HCC
ESTRO-EORTC Expert Guideline on Target Delineation and Radiotherapy for Stage I–III Small Cell Lung Cancer
Hesham ElGhazaly: Meeting Global Oncology Leaders at ASCO 2026
Christopher Jackson: If Innovation Is the Heart of Oncology, Then Access Must Be Its Conscience
Classify metastatic Renal Cell Carcinoma (RCC) prognosis using IMDC (International Metastatic RCC Database Consortium) criteria.
Check if YES (risk factor), leave unchecked if NO
Check if YES (risk factor), leave unchecked if NO
Check if YES (risk factor), leave unchecked if NO
Check if YES (risk factor), leave unchecked if NO
Check if YES (risk factor), leave unchecked if NO
Check if YES (risk factor), leave unchecked if NO
IMDC Risk Factors:
Risk Categories:
LLN = Lower Limit of Normal, ULN = Upper Limit of Normal
